158 related articles for article (PubMed ID: 1671830)
1. Modulation of mitomycin C-induced multidrug resistance in vitro.
Dorr RT; Liddil JD
Cancer Chemother Pharmacol; 1991; 27(4):290-4. PubMed ID: 1671830
[TBL] [Abstract][Full Text] [Related]
2. Mitomycin C cross-resistance induced by adriamycin in human ovarian cancer cells in vitro.
Mizuno K; Furuhashi Y; Maeda O; Iwata M; Misawa T; Kawai M; Kano T; Tomoda Y
Cancer Chemother Pharmacol; 1990; 26(5):333-9. PubMed ID: 1976451
[TBL] [Abstract][Full Text] [Related]
3. Cross-resistance of human multidrug-resistant cells to mitomycin C.
Yusa K; Sato W; Yamazaki A; Tsukahara S; Tsuruo T
Anticancer Res; 1991; 11(3):1301-4. PubMed ID: 1909515
[TBL] [Abstract][Full Text] [Related]
4. Differential effects of verapamil and quinine on the reversal of doxorubicin resistance in a human leukemia cell line.
Bennis S; Ichas F; Robert J
Int J Cancer; 1995 Jul; 62(3):283-90. PubMed ID: 7628869
[TBL] [Abstract][Full Text] [Related]
5. Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line model.
Lehnert M; Dalton WS; Roe D; Emerson S; Salmon SE
Blood; 1991 Jan; 77(2):348-54. PubMed ID: 1670760
[TBL] [Abstract][Full Text] [Related]
6. Sufficient levels of quinine in the serum circumvent the multidrug resistance of the human leukemic cell line K562/ADM.
Solary E; Velay I; Chauffert B; Bidan JM; Caillot D; Dumas M; Guy H
Cancer; 1991 Oct; 68(8):1714-9. PubMed ID: 1913513
[TBL] [Abstract][Full Text] [Related]
7. P-glycoprotein regulates chemosensitivity in early developmental stages of the mouse.
Elbling L; Berger W; Rehberger A; Waldhör T; Micksche M
FASEB J; 1993 Dec; 7(15):1499-506. PubMed ID: 7903262
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein overexpression cannot explain the complete doxorubicin-resistance phenotype in rat glioblastoma cell lines.
Huet S; Schott B; Robert J
Br J Cancer; 1992 Apr; 65(4):538-44. PubMed ID: 1348623
[TBL] [Abstract][Full Text] [Related]
9. Evidence for a constitutive, verapamil-sensitive, non-P-glycoprotein multidrug resistance phenotype in malignant glioma that is unaltered by radiochemotherapy in vivo.
Rieger L; Rieger J; Winter S; Streffer J; Esser P; Dichgans J; Meyermann R; Weller M
Acta Neuropathol; 2000 May; 99(5):555-62. PubMed ID: 10805101
[TBL] [Abstract][Full Text] [Related]
10. Comparison of uptake of mitomycin C and KW-2149 by murine P388 leukemia cells sensitive or resistant to mitomycin C.
Kobayashi E; Okabe M; Kono M; Arai H; Kasai M; Gomi K; Lee JH; Inaba M; Tsuruo T
Cancer Chemother Pharmacol; 1993; 32(1):20-4. PubMed ID: 8096440
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of cellular accumulation of cyclosporine by anti-P-glycoprotein monoclonal antibody MRK-16 and synergistic modulation of multidrug resistance.
Naito M; Tsuge H; Kuroko C; Koyama T; Tomida A; Tatsuta T; Heike Y; Tsuruo T
J Natl Cancer Inst; 1993 Feb; 85(4):311-6. PubMed ID: 7678867
[TBL] [Abstract][Full Text] [Related]
12. MDR1 gene expression: its effect on drug resistance to doxorubicin in human hepatocellular carcinoma cell lines.
Park JG; Lee SK; Hong IG; Kim HS; Lim KH; Choe KJ; Kim WH; Kim YI; Tsuruo T; Gottesman MM
J Natl Cancer Inst; 1994 May; 86(9):700-5. PubMed ID: 7908989
[TBL] [Abstract][Full Text] [Related]
13. Mitomycin C resistant L1210 leukemia cells: association with pleiotropic drug resistance.
Dorr RT; Liddil JD; Trent JM; Dalton WS
Biochem Pharmacol; 1987 Oct; 36(19):3115-20. PubMed ID: 3117061
[TBL] [Abstract][Full Text] [Related]
14. Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin.
Sadasivan R; Morgan R; Fabian C; Stephens R
Cancer Lett; 1991 May; 57(2):165-71. PubMed ID: 1673873
[TBL] [Abstract][Full Text] [Related]
15. Role of the MDR-1-encoded multiple drug resistance phenotype in prostate cancer cell lines.
Theyer G; Schirmböck M; Thalhammer T; Sherwood ER; Baumgartner G; Hamilton G
J Urol; 1993 Nov; 150(5 Pt 1):1544-7. PubMed ID: 8105110
[TBL] [Abstract][Full Text] [Related]
16. Competitive and non-competitive inhibition of the multidrug-resistance-associated P-glycoprotein ATPase--further experimental evidence for a multisite model.
Garrigos M; Mir LM; Orlowski S
Eur J Biochem; 1997 Mar; 244(2):664-73. PubMed ID: 9119038
[TBL] [Abstract][Full Text] [Related]
17. Characterization of multidrug resistance P-glycoprotein transport function with an organotechnetium cation.
Piwnica-Worms D; Rao VV; Kronauge JF; Croop JM
Biochemistry; 1995 Sep; 34(38):12210-20. PubMed ID: 7547962
[TBL] [Abstract][Full Text] [Related]
18. [Effect of quinine on the multiple drug resistance and intracellular distribution of pirarubicin in LR73 tumor cells: a comparative study with verapamil and S9788 by confocal laser microspectrofluorometry].
Belhoussine R; Morjani H; Manfait M
Bull Cancer; 1997 Apr; 84(4):343-9. PubMed ID: 9238156
[TBL] [Abstract][Full Text] [Related]
19. Reduced topoisomerase II and elevated alpha class glutathione S-transferase expression in a multidrug resistant CHO cell line highly cross-resistant to mitomycin C.
Hoban PR; Robson CN; Davies SM; Hall AG; Cattan AR; Hickson ID; Harris AL
Biochem Pharmacol; 1992 Feb; 43(4):685-93. PubMed ID: 1311588
[TBL] [Abstract][Full Text] [Related]
20. Reversal agent inhibition of the multidrug resistance pump in human leukemic lymphoblasts.
Wigler PW; Patterson FK
Biochim Biophys Acta; 1994 Jan; 1189(1):1-6. PubMed ID: 7905747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
